120
Participants
Start Date
August 31, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
PTMC Dermal Filler
A total of 120 subjects will receive treatment with PTMC Dermal Filler. The volume of filler injected will vary depending on the severity of the nasolabial fold. Injections will be administered by the investigator at the beginning of the study, with the injection technique, plane, and volume recorded. Touch-up treatments are permitted at the 1-month follow-up visit, if necessary.
Lead Sponsor
Aqpha Medical B.V.
INDUSTRY